CN113209204A - External medicine for treating hyperplasia of mammary glands and ovarian cyst - Google Patents

External medicine for treating hyperplasia of mammary glands and ovarian cyst Download PDF

Info

Publication number
CN113209204A
CN113209204A CN202110643029.1A CN202110643029A CN113209204A CN 113209204 A CN113209204 A CN 113209204A CN 202110643029 A CN202110643029 A CN 202110643029A CN 113209204 A CN113209204 A CN 113209204A
Authority
CN
China
Prior art keywords
parts
radix
stasis
blood
ovarian cyst
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202110643029.1A
Other languages
Chinese (zh)
Inventor
孙盼盼
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Liuzhou Yiguan Health Management Co ltd
Original Assignee
Liuzhou Yiguan Health Management Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Liuzhou Yiguan Health Management Co ltd filed Critical Liuzhou Yiguan Health Management Co ltd
Priority to CN202110643029.1A priority Critical patent/CN113209204A/en
Publication of CN113209204A publication Critical patent/CN113209204A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/63—Arthropods
    • A61K35/64—Insects, e.g. bees, wasps or fleas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A61K36/074—Ganoderma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/232—Angelica
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/238—Saposhnikovia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/27—Asclepiadaceae (Milkweed family), e.g. hoya
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/286—Carthamus (distaff thistle)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/288—Taraxacum (dandelion)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/32—Burseraceae (Frankincense family)
    • A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/35—Caprifoliaceae (Honeysuckle family)
    • A61K36/355—Lonicera (honeysuckle)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/36—Caryophyllaceae (Pink family), e.g. babysbreath or soapwort
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/486—Millettia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/536—Prunella or Brunella (selfheal)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
    • A61K36/708—Rheum (rhubarb)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A61K36/716—Clematis (leather flower)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/74—Rubiaceae (Madder family)
    • A61K36/748—Oldenlandia or Hedyotis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A61K36/756—Phellodendron, e.g. corktree
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/80—Scrophulariaceae (Figwort family)
    • A61K36/808—Scrophularia (figwort)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0041—Mammary glands, e.g. breasts, udder; Intramammary administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Insects & Arthropods (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to the technical field of traditional Chinese medicines, in particular to an external medicine for treating hyperplasia of mammary glands and ovarian cyst, which comprises the following raw materials in parts by weight: eupolyphaga Seu Steleophaga, cortex Phellodendri, Myrrha, Notoginseng radix, Ganoderma, flos Lonicerae, radix Angelicae sinensis, semen Vaccariae, Achyranthis radix, radix scrophulariae, radix Saposhnikoviae, Prunellae Spica, Carthami flos, Catechu, herba Taraxaci, sanguis Draxonis, Borneolum, herba Hedyotidis Diffusae, herba Taxilli, radix Clematidis, caulis et folium Periplocae Forrestii, caulis Spatholobi, and radix et rhizoma Rhei. The traditional Chinese medicine composition is exquisite in medicine, changes the problem of unsmooth qi and blood by promoting blood circulation and removing blood stasis, promotes blood circulation by promoting qi circulation, and leads meridians to be stasis and swollen, so as to treat the problems of stasis and swelling caused by unsmooth blood circulation, warms and leads meridians by promoting menstruation and dissipating stagnation, relaxes tendons and channels, strengthens the force of promoting blood circulation and removing blood stasis, is beneficial to relieving stasis and swelling, relieves pain and damp poison in vivo when relaxing tendons and channels by detoxifying, diminishing inflammation and relieving pain, has the advantages of supplementing various medicines, shortens the treatment course, greatly improves the treatment effect and brings good news to female patients.

Description

External medicine for treating hyperplasia of mammary glands and ovarian cyst
Technical Field
The invention relates to the technical field of traditional Chinese medicines, in particular to an external medicine for treating hyperplasia of mammary glands and ovarian cyst.
Background
Mammary gland hyperplasia and ovarian cyst belong to common female diseases, wherein the mammary gland hyperplasia refers to symptoms of mammary gland lumps, nodules and the like of a patient caused by high estrogen level caused by various reasons, essentially, normal structural disorder of mammary glands caused by hyperplasia of different degrees of mammary glands and mesenchyme and involution insufficiency is a benign mammary gland disease caused by abnormal normal development and degeneration process of mammary glands, the ovarian cyst is a liquid or solid filled sac-like structure formed in an ovary, the physiological cyst can automatically disappear after a period of months, the pathological cyst is treated according to symptoms, and the two female diseases are treated by adopting a traditional Chinese medicine ointment at present.
The traditional Chinese medicine ointment penetrates into subcutaneous tissues subcutaneously and is absorbed by micro blood vessels of a human body, so that a strong pharmacological effect is exerted to achieve a treatment effect, but the traditional Chinese medicine ointment on the market at present has a poor medicinal effect and a long treatment period. Therefore, the technical personnel in the field provide an external medicine for treating hyperplasia of mammary glands and ovarian cyst to solve the problems in the background technology.
Disclosure of Invention
The invention aims to provide an external medicine for treating hyperplasia of mammary glands and ovarian cyst, which aims to solve the problems in the background technology.
In order to achieve the purpose, the invention provides the following technical scheme: an external medicine for treating hyperplasia of mammary glands and ovarian cyst comprises the following raw materials in parts by weight: 13-30 parts of eupolyphaga, 25-35 parts of golden cypress, 28-38 parts of myrrh, 35-47 parts of pseudo-ginseng, 15-30 parts of lucid ganoderma, 25-35 parts of honeysuckle, 25-37 parts of angelica, 37-45 parts of cowherb seed, 15-25 parts of achyranthes root, 5-18 parts of figwort root, 15-27 parts of divaricate saposhnikovia root, 15-30 parts of selfheal, 35-45 parts of safflower, 15-30 parts of catechu, 25-35 parts of dandelion, 18-28 parts of dragon's blood, 1-7 parts of borneol, 18-25 parts of ophiorrhiza pumila, 15-30 parts of parasitic loranthus, 15-30 parts of clematis root, 15-30 parts of periploca forrestii, 15-30 parts of suberect spatholobus stem and 15-30 parts of rhubarb.
As a further aspect of the invention: the feed also comprises the following raw materials in parts by weight: 20 parts of eupolyphaga, 30 parts of golden cypress, 30 parts of myrrh, 40 parts of pseudo-ginseng, 20 parts of lucid ganoderma, 30 parts of honeysuckle, 30 parts of angelica, 40 parts of cowherb seed, 20 parts of achyranthes, 10 parts of figwort root, 20 parts of divaricate saposhnikovia root, 20 parts of selfheal, 40 parts of safflower, 20 parts of catechu, 30 parts of dandelion, 20 parts of dragon's blood, 5 parts of borneol, 20 parts of oldenlandia diffusa, 20 parts of parasitic loranthus, 20 parts of radix clematidis, 20 parts of caulis periplocae, 20 parts of caulis spatholobi and 20 parts of rhubarb.
An external medicine for treating hyperplasia of mammary glands and ovarian cyst comprises the following preparation steps:
s1, removing impurities from Eupolyphaga Seu Steleophaga, cortex Phellodendri, Myrrha, radix Notoginseng, Ganoderma, flos Lonicerae, radix Angelicae sinensis, semen Vaccariae, radix Achyranthis bidentatae, radix scrophulariae, radix Saposhnikoviae, Spica Prunellae, flos Carthami, Catechu, herba Taraxaci, sanguis Draxonis, Borneolum Syntheticum, herba Hedyotidis Diffusae, herba Taxilli, radix Clematidis, caulis et folium Periplocae Forrestii, caulis Spatholobi, and radix Et rhizoma Rhei, drying, mixing, grinding into fine powder, and sieving with 100 mesh sieve to obtain mixed powder;
s2, putting 30g-50g of the mixed powder into a gauze bag with the length of 11cm and the width of 7cm, and soaking in 100ml of white spirit for 12 hours;
s3, taking out the gauze bag soaked in Chinese liquor, blending with boiled water or Chinese liquor to obtain paste, and making into topical preparation.
As a further aspect of the invention: the alcohol content of the white spirit in the S2 and the S3 is 50 degrees.
B, ground beetle: salty and cold in taste, and small in toxicity, enters liver meridian, mainly has the function of removing blood stasis, and is used for reuniting bones and muscles, blood stasis amenorrhea and abdominal mass;
phellodendron bark: the bitter taste and cold nature enter kidney meridian, and mainly have the functions of clearing heat and removing toxicity, purging fire and drying dampness;
myrrh: bitter and pungent in flavor, warm in nature, and nontoxic, enters liver, spleen, heart and kidney meridians, and is mainly used for treating blood stasis and pain in chest and abdomen, dysmenorrhea, amenorrhea, abdominal mass, traumatic injury, carbuncle, sore and ulcer, intestinal abscess, conjunctival congestion, swelling and pain, and has effects of promoting blood circulation, relieving pain, detumescence and promoting granulation;
pseudo-ginseng: sweet in nature and taste, slightly bitter and warm, enters liver and stomach meridians, and has the effects of removing blood stasis, stopping bleeding, promoting blood circulation and relieving pain;
ganoderma lucidum: the tea is sweet and bitter in taste and neutral in nature, enters heart, lung, liver and spleen channels, and can nourish heart, calm nerves, nourish lung, tonify qi, regulate qi, remove blood stasis, nourish liver and invigorate spleen;
honeysuckle flower: is cold in nature and sweet in taste, enters lung, heart and stomach meridians, and has the effects of clearing away heat and toxic materials, resisting inflammation, tonifying deficiency and treating wind;
chinese angelica: the wine is warm in nature, sweet and pungent in taste, has the effects of tonifying blood and regulating blood, regulating menstruation and relieving pain, moistening dryness and lubricating intestines, resisting cancer, resisting aging and preventing aging and immunity, and has the functions of tonifying blood and regulating blood;
seed of cowherb: the medicine is bitter and mild, belongs to liver and stomach channels, and has the effects of activating blood and stimulating the menstrual flow, promoting lactation and reducing swelling, and inducing diuresis and treating stranguria;
achyranthes root: nature and taste: bitter, sour and neutral, enter liver and kidney meridians, have the effects of promoting blood circulation, removing blood stasis, nourishing liver and kidney, and strengthening tendons and bones, and are mainly used for treating irregular menstruation, dysmenorrhea, amenorrhea, postpartum abdominal pain and traumatic injury pain;
figwort root: bitter, sweet, salty and cold in nature, enters lung, stomach and kidney channels, and has the functions of clearing away heat and toxic materials, cooling blood and nourishing yin;
wind prevention: pungent and sweet in flavor, slightly warm in nature, entering bladder, lung, spleen and liver channels, and having effects of dispelling pathogenic wind, clearing heat, relieving exterior syndrome, relieving diarrhea and stopping bleeding;
selfheal: bitter, pungent and cold in property, entering liver meridian, and has effects of clearing liver fire and resolving stagnation;
safflower: the property of the medicine is pungent and warm, and the medicine has the effects of invigorating the circulation of blood, stimulating the menstrual flow, dissipating blood stasis and relieving pain;
catechu: bitter, astringent and cool in nature, and has effects of promoting blood circulation, healing wound, stopping bleeding, promoting granulation, eliminating dampness, healing sore, clearing lung-heat and eliminating phlegm;
dandelion: bitter and sweet taste and cold nature, belongs to liver and stomach meridians, and has the effects of clearing away heat and toxic materials, resolving carbuncle and resolving hard mass, and promoting diuresis and treating stranguria;
dragon's blood: has pungent and mild nature and flavor, enters liver and heart meridians, and has effects of removing blood stasis, relieving pain, stopping bleeding and healing sore;
borneol: has pungent and bitter taste, and has effects of dredging orifices, dispelling stagnated fire, inducing resuscitation, refreshing brain, removing nebula, improving eyesight, relieving swelling and pain;
all-grass of creeping snakehead: bitter and light taste, cold nature, has effects of clearing heat and detoxicating, relieving pain and resolving hard mass, promoting urination and removing dampness;
parasitic loranthus: bitter in nature and taste, mild in nature, and entering liver and kidney meridians, and has effects of dispelling pathogenic wind and removing dampness, nourishing liver and kidney, strengthening tendons and bones, and preventing miscarriage;
clematis root: the product is pungent, salty and warm in taste, enters bladder meridian, and has effects of dispelling pathogenic wind, removing dampness, dredging collaterals, relieving pain, promoting urination and dredging meridian;
black-bone vine: pungent and warm in flavor, and has the effects of dispelling wind-damp, dredging channels and collaterals, and promoting blood circulation;
caulis spatholobi: the wine is bitter in taste, slightly sweet and warm in nature, enters liver and kidney channels, and has the effects of promoting blood circulation, enriching blood, regulating menstruation, relieving pain, relaxing muscles and tendons and activating collaterals;
rhubarb: is bitter in taste and cold in nature, enters stomach, large intestine, liver and spleen channels, and has the effects of purging pathogenic accumulation, cooling blood, stopping bleeding, clearing pathogenic fire, removing toxic substances, promoting blood circulation, removing blood stasis, and clearing away damp-heat.
Compared with the prior art, the invention has the beneficial effects that: the traditional Chinese medicine composition is exquisite in medication, the medicine effects of the used medicinal materials surround aspects of clearing heat, promoting diuresis, promoting blood circulation, removing blood stasis, clearing heat, detoxifying, dredging channels, dissipating stagnation, diminishing inflammation and relieving pain, the problem of unsmooth qi and blood is solved by promoting blood circulation, blood circulation is realized by promoting blood circulation, and stasis, swelling and swelling are eliminated by dredging channels, so that the problems of swelling and obstruction caused by unsmooth blood circulation are treated, the effects of warming and dredging channels by promoting blood circulation, relaxing tendons and dredging collaterals are realized by promoting blood circulation, the stasis and swelling are facilitated to be dissipated, pain and damp toxin in vivo are relieved by detoxifying, diminishing inflammation and relieving pain during relaxing tendons and dredging collaterals, the medicines supplement each other, the treatment course is shortened, the treatment effect is greatly improved, and good news is brought to female patients.
Detailed Description
Example 1
In the embodiment of the invention, the external medicine for treating hyperplasia of mammary glands and ovarian cyst comprises the following raw materials in parts by weight: 13-30 parts of eupolyphaga, 25-35 parts of golden cypress, 28-38 parts of myrrh, 35-47 parts of pseudo-ginseng, 15-30 parts of lucid ganoderma, 25-35 parts of honeysuckle, 25-37 parts of angelica, 37-45 parts of cowherb seed, 15-25 parts of achyranthes root, 5-18 parts of figwort root, 15-27 parts of divaricate saposhnikovia root, 15-30 parts of selfheal, 35-45 parts of safflower, 15-30 parts of catechu, 25-35 parts of dandelion, 18-28 parts of dragon's blood, 1-7 parts of borneol, 18-25 parts of ophiorrhiza pumila, 15-30 parts of parasitic loranthus, 15-30 parts of clematis root, 15-30 parts of periploca forrestii, 15-30 parts of suberect spatholobus stem and 15-30 parts of rhubarb.
An external medicine for treating hyperplasia of mammary glands and ovarian cyst comprises the following preparation steps:
s1, removing impurities from Eupolyphaga Seu Steleophaga, cortex Phellodendri, Myrrha, radix Notoginseng, Ganoderma, flos Lonicerae, radix Angelicae sinensis, semen Vaccariae, radix Achyranthis bidentatae, radix scrophulariae, radix Saposhnikoviae, Spica Prunellae, flos Carthami, Catechu, herba Taraxaci, sanguis Draxonis, Borneolum Syntheticum, herba Hedyotidis Diffusae, herba Taxilli, radix Clematidis, caulis et folium Periplocae Calophyllae, caulis Spatholobi, and radix Et rhizoma Rhei, drying, mixing, grinding into fine powder, and sieving with 100 mesh sieve to obtain mixed powder;
s2, putting 30g-50g of the mixed powder into a gauze bag with the length of 11cm and the width of 7cm, and soaking in 100ml of white spirit for 12 hours;
s3, taking out the gauze bag soaked in Chinese liquor, blending with boiled water or Chinese liquor to obtain paste, and making into topical preparation.
As a further aspect of the invention: the alcohol content of the white spirit in S2 and S3 is 50 degrees.
Example 2
The preparation was carried out exactly according to the protocol of example 1, differing from example 1 by: the feed comprises the following raw materials in parts by weight: 20 parts of eupolyphaga, 30 parts of golden cypress, 30 parts of myrrh, 40 parts of pseudo-ginseng, 20 parts of lucid ganoderma, 30 parts of honeysuckle, 30 parts of angelica, 40 parts of cowherb seed, 20 parts of achyranthes, 10 parts of figwort root, 20 parts of divaricate saposhnikovia root, 20 parts of selfheal, 40 parts of safflower, 20 parts of catechu, 30 parts of dandelion, 20 parts of dragon's blood, 5 parts of borneol, 20 parts of oldenlandia diffusa, 20 parts of parasitic loranthus, 20 parts of radix clematidis, 20 parts of caulis periplocae, 20 parts of caulis spatholobi and 20 parts of rhubarb.
Test example:
test objects: 90 patients (45 each of breast hyperplasia and ovarian cyst) were enrolled, with breast hyperplasia divided into four grades: 15 mild hyperplasia (3 courses), 15 moderate hyperplasia (6 courses), 15 severe hyperplasia (10 courses), and ovarian cyst (3 courses);
and (3) testing groups: in the application, the number of the test persons is averagely distributed in the embodiment 1 and the embodiment 2 and any common product (reference example) on the market;
the test method comprises the following steps: applying the gauze bag on the affected part, covering the medicated bag with plastic film, sealing and fixing the plastic film with medical adhesive tape, not allowing the plastic film to leak air, changing once after 1 hr, 10 days as a treatment course, and consolidating for 2 treatment courses after the lump disappears after the course of disease is more than 5 years;
and (3) testing results: revisits were performed after the corresponding treatment period to obtain the following data:
Figure BDA0003107833010000051
by combining the data, the curative effect of the embodiment 1 and the embodiment 2 of the application is better than that of the reference example, so that the treatment course is shortened, the pain duration of a patient is reduced, and the treatment cost is effectively reduced.
In summary, the following steps: the traditional Chinese medicine composition is exquisite in medication, the medicine effects of the used medicinal materials surround aspects of clearing heat, promoting diuresis, promoting blood circulation, removing blood stasis, clearing heat, detoxifying, dredging channels, dissipating stagnation, diminishing inflammation and relieving pain, the problem of unsmooth qi and blood is solved by promoting blood circulation, blood circulation is realized by promoting blood circulation, and stasis, swelling and swelling are eliminated by dredging channels, so that the problems of swelling and obstruction caused by unsmooth blood circulation are treated, the effects of warming and dredging channels by promoting blood circulation, relaxing tendons and dredging collaterals are realized by promoting blood circulation, the stasis and swelling are facilitated to be dissipated, pain and damp toxin in vivo are relieved by detoxifying, diminishing inflammation and relieving pain during relaxing tendons and dredging collaterals, the medicines supplement each other, the treatment course is shortened, the treatment effect is greatly improved, and good news is brought to female patients.
The above description is only for the preferred embodiment of the present invention, but the scope of the present invention is not limited thereto, and any person skilled in the art should be considered to be within the technical scope of the present invention, and the technical solutions and the inventive concepts thereof according to the present invention are equivalent to or changed within the technical scope of the present invention.

Claims (4)

1. The external medicine for treating hyperplasia of mammary glands and ovarian cyst is characterized by comprising the following raw materials in parts by weight: 13-30 parts of eupolyphaga, 25-35 parts of golden cypress, 28-38 parts of myrrh, 35-47 parts of pseudo-ginseng, 15-30 parts of lucid ganoderma, 25-35 parts of honeysuckle, 25-37 parts of angelica, 37-45 parts of cowherb seed, 15-25 parts of achyranthes root, 5-18 parts of figwort root, 15-27 parts of divaricate saposhnikovia root, 15-30 parts of selfheal, 35-45 parts of safflower, 15-30 parts of catechu, 25-35 parts of dandelion, 18-28 parts of dragon's blood, 1-7 parts of borneol, 18-25 parts of ophiorrhiza pumila, 15-30 parts of parasitic loranthus, 15-30 parts of clematis root, 15-30 parts of periploca forrestii, 15-30 parts of suberect spatholobus stem and 15-30 parts of rhubarb.
2. The external medicine for treating hyperplasia of mammary glands and ovarian cyst according to claim 1, which is characterized by further comprising the following raw materials in parts by weight: 20 parts of eupolyphaga, 30 parts of golden cypress, 30 parts of myrrh, 40 parts of pseudo-ginseng, 20 parts of lucid ganoderma, 30 parts of honeysuckle, 30 parts of angelica, 40 parts of cowherb seed, 20 parts of achyranthes, 10 parts of figwort root, 20 parts of divaricate saposhnikovia root, 20 parts of selfheal, 40 parts of safflower, 20 parts of catechu, 30 parts of dandelion, 20 parts of dragon's blood, 5 parts of borneol, 20 parts of oldenlandia diffusa, 20 parts of parasitic loranthus, 20 parts of radix clematidis, 20 parts of caulis periplocae, 20 parts of caulis spatholobi and 20 parts of rhubarb.
3. The external medicine for treating hyperplasia of mammary glands and ovarian cyst as claimed in any one of claims 1-2, which comprises the following preparation steps:
s1, removing impurities from Eupolyphaga Seu Steleophaga, cortex Phellodendri, Myrrha, radix Notoginseng, Ganoderma, flos Lonicerae, radix Angelicae sinensis, semen Vaccariae, radix Achyranthis bidentatae, radix scrophulariae, radix Saposhnikoviae, Spica Prunellae, flos Carthami, Catechu, herba Taraxaci, sanguis Draxonis, Borneolum Syntheticum, herba Hedyotidis Diffusae, herba Taxilli, radix Clematidis, caulis et folium Periplocae Forrestii, caulis Spatholobi, and radix Et rhizoma Rhei, drying, mixing, grinding into fine powder, and sieving with 100 mesh sieve to obtain mixed powder;
s2, putting 30g-50g of the mixed powder into a gauze bag with the length of 11cm and the width of 7cm, and soaking in 100ml of white spirit for 12 hours;
s3, taking out the gauze bag soaked in Chinese liquor, blending with boiled water or Chinese liquor to obtain paste, and making into topical preparation.
4. The external medicine for treating breast hyperplasia and ovarian cyst as claimed in claim 3, wherein the alcohol content of the distilled spirit in S2 and S3 is 50 degrees.
CN202110643029.1A 2021-06-09 2021-06-09 External medicine for treating hyperplasia of mammary glands and ovarian cyst Pending CN113209204A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202110643029.1A CN113209204A (en) 2021-06-09 2021-06-09 External medicine for treating hyperplasia of mammary glands and ovarian cyst

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202110643029.1A CN113209204A (en) 2021-06-09 2021-06-09 External medicine for treating hyperplasia of mammary glands and ovarian cyst

Publications (1)

Publication Number Publication Date
CN113209204A true CN113209204A (en) 2021-08-06

Family

ID=77083408

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202110643029.1A Pending CN113209204A (en) 2021-06-09 2021-06-09 External medicine for treating hyperplasia of mammary glands and ovarian cyst

Country Status (1)

Country Link
CN (1) CN113209204A (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102631453A (en) * 2012-05-09 2012-08-15 张静 External medicament for treating hyperplasia of mammary glands and ovarian cyst
CN104623512A (en) * 2013-11-08 2015-05-20 张秋枝 Mammary gland hyperplasia emplastrum
CN110025720A (en) * 2019-04-19 2019-07-19 杨朝龙 A kind of Chinese medicine preparation of mass dissipating and swelling eliminating

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102631453A (en) * 2012-05-09 2012-08-15 张静 External medicament for treating hyperplasia of mammary glands and ovarian cyst
CN104623512A (en) * 2013-11-08 2015-05-20 张秋枝 Mammary gland hyperplasia emplastrum
CN110025720A (en) * 2019-04-19 2019-07-19 杨朝龙 A kind of Chinese medicine preparation of mass dissipating and swelling eliminating

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
王爱玲，等: "乳块消贴治疗乳腺增生56例", 《中医外治杂志》 *
耐华，等: "中药保留灌肠配合外敷治疗慢性盆腔炎56例", 《新疆中医药》 *

Similar Documents

Publication Publication Date Title
CN101057942B (en) External applied medicine ointment for treating diabetes foot and its preparing method
CN102552804B (en) Chinese medicine composite for curing verruca plantaris
CN107095905A (en) A kind of healthful moxibustion bar and moxibustion cream
CN107412640B (en) External ointment for assisting acupuncture and moxibustion physiotherapy
CN101239134B (en) Speckle-removing medicinal composition
CN105999105A (en) Traditional Chinese medicine composition for treating bedsores and diabetic ulcers and preparation method thereof
CN103330872B (en) Method for preparing snake wound rehabilitation medicament
CN103330873B (en) Snake wound rehabilitation medicament
CN113209204A (en) External medicine for treating hyperplasia of mammary glands and ovarian cyst
CN113230336A (en) Traditional Chinese medicine plaster for treating shoulder, neck, waist and leg pain
CN103223158B (en) External medicine for treating alopecia
CN105250758A (en) Traditional Chinese medicine composition for treating diabetes
CN105561270A (en) Analgesic Chinese herbal medicine for external application and preparation method thereof
CN105327244A (en) Traditional Chinese medicine composition containing folium artemisiae argyi and used for treating bedsores and preparing method thereof
CN101518579B (en) Pressure stabilizing deoppilant and preparation process
CN106729939B (en) A kind of dressing for treating bedsore
CN105213609A (en) A kind of Chinese medicine composition for the treatment of decubital ulcer and preparation method thereof
CN111358915A (en) Traditional Chinese medicine for treating congenital muscular torticollis and preparation method thereof
CN100548336C (en) A kind of Chinese medicine composition of orally taken for curing intercostal neuralgia
CN108030828B (en) Traditional Chinese medicine preparation for preventing skin flap necrosis after breast cancer operation and preparation method thereof
CN115813995A (en) A paste for treating diabetes and hypertension syndrome
CN105816737A (en) Foot bath formula for treating insomnia
CN113197952A (en) Dampness rash clearing composition for children and preparation method and application thereof
CN112870312A (en) Medicinal liquor with effects of promoting blood circulation and removing blood stasis and preparation method thereof
CN110859922A (en) Ointment for repairing skin wound and hyperplastic scar and preparation method thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20210806

RJ01 Rejection of invention patent application after publication